Page last updated: 2024-11-13

wms 1410

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID49832807
CHEMBL ID1289626
SCHEMBL ID3424183
MeSH IDM0554906

Synonyms (5)

Synonym
CHEMBL1289626 ,
wms-1410
bdbm50331291
(+/-)-3-(4-phenylbutyl)-2,3,4,5-tetrahydro-1h-3-benzazepine-1,7-diol
SCHEMBL3424183
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (7)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Cocaine esteraseHomo sapiens (human)Ki0.19400.00630.98358.0000AID1272497
Metabotropic glutamate receptor 5Homo sapiens (human)IC50 (µMol)0.56000.00050.439410.0000AID538924
Glutamate receptor ionotropic, NMDA 1Homo sapiens (human)IC50 (µMol)0.01850.00101.88779.8000AID538753
Glutamate receptor ionotropic, NMDA 1Homo sapiens (human)Ki0.03730.00120.48246.0000AID1272496; AID1462752; AID538755
Glutamate receptor ionotropic, NMDA 2BHomo sapiens (human)IC50 (µMol)0.01850.00401.33259.8000AID538753
Glutamate receptor ionotropic, NMDA 2BHomo sapiens (human)Ki0.04900.00120.32686.0000AID1272496; AID1462752; AID1690205; AID538755
Sigma intracellular receptor 2Homo sapiens (human)Ki0.01000.00010.83604.6005AID1690207
Sigma non-opioid intracellular receptor 1Cavia porcellus (domestic guinea pig)Ki0.19400.00000.338510.0000AID1369086; AID538759
Sigma non-opioid intracellular receptor 1Homo sapiens (human)Ki0.19200.00000.490110.0000AID1272497; AID1690206
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (63)

Processvia Protein(s)Taxonomy
prostaglandin metabolic processCocaine esteraseHomo sapiens (human)
xenobiotic metabolic processCocaine esteraseHomo sapiens (human)
catabolic processCocaine esteraseHomo sapiens (human)
desensitization of G protein-coupled receptor signaling pathwayMetabotropic glutamate receptor 5Homo sapiens (human)
regulation of DNA-templated transcriptionMetabotropic glutamate receptor 5Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathwayMetabotropic glutamate receptor 5Homo sapiens (human)
protein kinase C-activating G protein-coupled receptor signaling pathwayMetabotropic glutamate receptor 5Homo sapiens (human)
phospholipase C-activating G protein-coupled glutamate receptor signaling pathwayMetabotropic glutamate receptor 5Homo sapiens (human)
G protein-coupled glutamate receptor signaling pathwayMetabotropic glutamate receptor 5Homo sapiens (human)
chemical synaptic transmissionMetabotropic glutamate receptor 5Homo sapiens (human)
learning or memoryMetabotropic glutamate receptor 5Homo sapiens (human)
learningMetabotropic glutamate receptor 5Homo sapiens (human)
locomotory behaviorMetabotropic glutamate receptor 5Homo sapiens (human)
positive regulation of MAPK cascadeMetabotropic glutamate receptor 5Homo sapiens (human)
positive regulation of long-term neuronal synaptic plasticityMetabotropic glutamate receptor 5Homo sapiens (human)
synapse organizationMetabotropic glutamate receptor 5Homo sapiens (human)
positive regulation of calcium-mediated signalingMetabotropic glutamate receptor 5Homo sapiens (human)
cognitionMetabotropic glutamate receptor 5Homo sapiens (human)
regulation of postsynaptic membrane potentialMetabotropic glutamate receptor 5Homo sapiens (human)
regulation of postsynaptic cytosolic calcium ion concentrationMetabotropic glutamate receptor 5Homo sapiens (human)
cellular response to amyloid-betaMetabotropic glutamate receptor 5Homo sapiens (human)
regulation of synaptic transmission, glutamatergicMetabotropic glutamate receptor 5Homo sapiens (human)
trans-synaptic signaling by endocannabinoid, modulating synaptic transmissionMetabotropic glutamate receptor 5Homo sapiens (human)
cellular response to amyloid-betaGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
monoatomic cation transportGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
brain developmentGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
visual learningGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
positive regulation of calcium ion transport into cytosolGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
propylene metabolic processGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
calcium-mediated signalingGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
regulation of membrane potentialGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
response to ethanolGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
regulation of synaptic plasticityGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
regulation of neuronal synaptic plasticityGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
protein heterotetramerizationGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
positive regulation of synaptic transmission, glutamatergicGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
calcium ion homeostasisGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
excitatory postsynaptic potentialGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
calcium ion transmembrane import into cytosolGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
monoatomic cation transmembrane transportGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
excitatory chemical synaptic transmissionGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
positive regulation of reactive oxygen species biosynthetic processGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
regulation of monoatomic cation transmembrane transportGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
response to glycineGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
positive regulation of excitatory postsynaptic potentialGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
chemical synaptic transmissionGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
glutamate receptor signaling pathwayGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
chemical synaptic transmissionGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
brain developmentGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
learning or memoryGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
calcium-mediated signalingGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
response to ethanolGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
regulation of synaptic plasticityGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
regulation of neuronal synaptic plasticityGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
protein heterotetramerizationGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
positive regulation of synaptic transmission, glutamatergicGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
calcium ion transmembrane import into cytosolGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
monoatomic cation transmembrane transportGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
excitatory chemical synaptic transmissionGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
regulation of presynaptic membrane potentialGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
negative regulation of dendritic spine maintenanceGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
regulation of monoatomic cation transmembrane transportGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
positive regulation of excitatory postsynaptic potentialGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
positive regulation of cysteine-type endopeptidase activityGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
long-term synaptic potentiationGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
excitatory postsynaptic potentialGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
regulation of cell growthSigma intracellular receptor 2Homo sapiens (human)
regulation of intracellular lipid transportSigma intracellular receptor 2Homo sapiens (human)
regulation of intracellular cholesterol transportSigma intracellular receptor 2Homo sapiens (human)
cholesterol homeostasisSigma intracellular receptor 2Homo sapiens (human)
positive regulation of wound healingSigma intracellular receptor 2Homo sapiens (human)
positive regulation of lipoprotein transportSigma intracellular receptor 2Homo sapiens (human)
lipid transportSigma non-opioid intracellular receptor 1Homo sapiens (human)
nervous system developmentSigma non-opioid intracellular receptor 1Homo sapiens (human)
G protein-coupled opioid receptor signaling pathwaySigma non-opioid intracellular receptor 1Homo sapiens (human)
regulation of neuron apoptotic processSigma non-opioid intracellular receptor 1Homo sapiens (human)
protein homotrimerizationSigma non-opioid intracellular receptor 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (30)

Processvia Protein(s)Taxonomy
methylumbelliferyl-acetate deacetylase activityCocaine esteraseHomo sapiens (human)
carboxylesterase activityCocaine esteraseHomo sapiens (human)
carboxylic ester hydrolase activityCocaine esteraseHomo sapiens (human)
G protein-coupled receptor activityMetabotropic glutamate receptor 5Homo sapiens (human)
protein bindingMetabotropic glutamate receptor 5Homo sapiens (human)
glutamate receptor activityMetabotropic glutamate receptor 5Homo sapiens (human)
protein tyrosine kinase activator activityMetabotropic glutamate receptor 5Homo sapiens (human)
A2A adenosine receptor bindingMetabotropic glutamate receptor 5Homo sapiens (human)
identical protein bindingMetabotropic glutamate receptor 5Homo sapiens (human)
protein tyrosine kinase bindingMetabotropic glutamate receptor 5Homo sapiens (human)
adenylate cyclase inhibiting G protein-coupled glutamate receptor activityMetabotropic glutamate receptor 5Homo sapiens (human)
neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentrationMetabotropic glutamate receptor 5Homo sapiens (human)
G protein-coupled receptor activity involved in regulation of postsynaptic membrane potentialMetabotropic glutamate receptor 5Homo sapiens (human)
NMDA glutamate receptor activityGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
calcium channel activityGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
amyloid-beta bindingGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
NMDA glutamate receptor activityGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
calcium ion bindingGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
protein bindingGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
calmodulin bindingGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
glycine bindingGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
glutamate bindingGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
glutamate-gated calcium ion channel activityGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
protein-containing complex bindingGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
signaling receptor activityGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
ligand-gated monoatomic ion channel activityGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
amyloid-beta bindingGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
NMDA glutamate receptor activityGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
protein bindingGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
zinc ion bindingGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
glycine bindingGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
glutamate bindingGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
glutamate-gated calcium ion channel activityGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potentialGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
protein bindingSigma intracellular receptor 2Homo sapiens (human)
oxysterol bindingSigma intracellular receptor 2Homo sapiens (human)
cholesterol bindingSigma intracellular receptor 2Homo sapiens (human)
G protein-coupled opioid receptor activitySigma non-opioid intracellular receptor 1Homo sapiens (human)
protein bindingSigma non-opioid intracellular receptor 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (39)

Processvia Protein(s)Taxonomy
endoplasmic reticulumCocaine esteraseHomo sapiens (human)
endoplasmic reticulum lumenCocaine esteraseHomo sapiens (human)
intracellular membrane-bounded organelleCocaine esteraseHomo sapiens (human)
dendriteMetabotropic glutamate receptor 5Homo sapiens (human)
cytoplasmMetabotropic glutamate receptor 5Homo sapiens (human)
plasma membraneMetabotropic glutamate receptor 5Homo sapiens (human)
dendritic spineMetabotropic glutamate receptor 5Homo sapiens (human)
dendritic shaftMetabotropic glutamate receptor 5Homo sapiens (human)
astrocyte projectionMetabotropic glutamate receptor 5Homo sapiens (human)
Schaffer collateral - CA1 synapseMetabotropic glutamate receptor 5Homo sapiens (human)
glutamatergic synapseMetabotropic glutamate receptor 5Homo sapiens (human)
postsynaptic density membraneMetabotropic glutamate receptor 5Homo sapiens (human)
plasma membraneMetabotropic glutamate receptor 5Homo sapiens (human)
cytoplasmGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
plasma membraneGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
synaptic vesicleGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
cell surfaceGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
postsynaptic densityGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
NMDA selective glutamate receptor complexGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
dendriteGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
neuron projectionGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
synaptic cleftGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
terminal boutonGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
dendritic spineGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
synapseGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
postsynaptic membraneGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
excitatory synapseGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
synaptic membraneGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
synapseGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
plasma membraneGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
neuron projectionGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
cytoplasmGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
lysosomeGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
late endosomeGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
cytoskeletonGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
plasma membraneGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
cell surfaceGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
postsynaptic densityGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
NMDA selective glutamate receptor complexGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
neuron projectionGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
postsynaptic membraneGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
synaptic membraneGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
plasma membraneGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
postsynaptic density membraneGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
endoplasmic reticulumSigma intracellular receptor 2Homo sapiens (human)
lysosomeSigma intracellular receptor 2Homo sapiens (human)
endoplasmic reticulumSigma intracellular receptor 2Homo sapiens (human)
rough endoplasmic reticulumSigma intracellular receptor 2Homo sapiens (human)
plasma membraneSigma intracellular receptor 2Homo sapiens (human)
rough endoplasmic reticulum membraneSigma intracellular receptor 2Homo sapiens (human)
nuclear membraneSigma intracellular receptor 2Homo sapiens (human)
nuclear envelopeSigma non-opioid intracellular receptor 1Homo sapiens (human)
nuclear inner membraneSigma non-opioid intracellular receptor 1Homo sapiens (human)
nuclear outer membraneSigma non-opioid intracellular receptor 1Homo sapiens (human)
endoplasmic reticulumSigma non-opioid intracellular receptor 1Homo sapiens (human)
endoplasmic reticulum membraneSigma non-opioid intracellular receptor 1Homo sapiens (human)
lipid dropletSigma non-opioid intracellular receptor 1Homo sapiens (human)
cytosolSigma non-opioid intracellular receptor 1Homo sapiens (human)
postsynaptic densitySigma non-opioid intracellular receptor 1Homo sapiens (human)
membraneSigma non-opioid intracellular receptor 1Homo sapiens (human)
growth coneSigma non-opioid intracellular receptor 1Homo sapiens (human)
cytoplasmic vesicleSigma non-opioid intracellular receptor 1Homo sapiens (human)
anchoring junctionSigma non-opioid intracellular receptor 1Homo sapiens (human)
postsynaptic density membraneSigma non-opioid intracellular receptor 1Homo sapiens (human)
endoplasmic reticulumSigma non-opioid intracellular receptor 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (157)

Assay IDTitleYearJournalArticle
AID538900Displacement of [3H]Haloperidol from Sigma1 receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID1378103n-Octanol-buffer distribution coefficient, log D of the compound at pH 7.4 by mass spectrometry based shake flask method2017European journal of medicinal chemistry, Sep-29, Volume: 138Deconstruction - reconstruction approach to analyze the essential structural elements of tetrahydro-3-benzazepine-based antagonists of GluN2B subunit containing NMDA receptors.
AID538902Displacement of [3H]-SR-140333 from tachykinin NK1 receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538906Displacement of [3H]-Ifenprodil from NMDA receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538887Displacement of [3H]N-Methyl-scopolamine from muscarinic M3 receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538926Displacement of [125I]-IL-2 from interleukin IL-2 receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538759Displacement of [3H](+)-pentazocine from sigma1 receptor guinea pig brain after 180 mins scintillation counting2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538797Displacement of [3H]-TCP from NMDA phencyclidine receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538791Displacement of [3H]Flunitrazepam from benzodiazepine central/GABAA receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538960Displacement of radiolabeled ZIPtide from PHKG2 at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538959Displacement of radiolabeled PARK substrate peptide from MAPKAPK5 at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538778Displacement of [125I]-Cyanopindolol from adrenergic alpha1 receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID1690207Binding affinity to Sigma 2 receptor (unknown origin)
AID538788Displacement of [125I]-EGF from epidermal growth factor receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538893Displacement of [3H]Diprenorphine from mu opioid receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538760Displacement of [3H]di-o-tolylguanidine from sigma2 receptor rat liver membranes after 180 mins scintillation counting2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538753Antagonist activity at human recombinant NR1-1a/NR2B receptor expressed in mouse L(tk-) cells assessed as inhibition of (S)-glutamate/glycine-stimulated excitotoxicity treated 30 mins before (S)-glutamate/glycine challenge measured after 4 hrs by LDH rele2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538938Displacement of radiolabeled kynuramine from MAO-A at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538910Displacement of radiolabeled Ac-YVAD-AMC from CASP1 at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538781Displacement of [3H]-Bradykinin from bradykinin B2 receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID1369086Displacement of [3H]-(+)-Pentazocine from sigma 1 receptor in guinea pig brain cortex membranes after 120 mins by scintillation counting analysis2018Bioorganic & medicinal chemistry, 01-15, Volume: 26, Issue:2
2-Methyltetrahydro-3-benzazepin-1-ols - The missing link in SAR of GluN2B selective NMDA receptor antagonists.
AID538762Selectivity ratio of Ki for human recombinant NR1a/NR2B receptor to Ki for guinea pig sigma1 receptor2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538773Displacement of [125I]-AB-MECA from adenosine A3 receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538755Displacement of [3H]ifenprodil from human recombinant NR1-1a/NR2B receptor expressed in mouse L(tk-) cells after 120 mins by scintillation counting2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538897Displacement of [35S] ATP-alpha-S from purinergic P2Y receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538920Displacement of [125I]-MIP-1-beta from chemokine CCR5 receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538795Displacement of [3H]-CGP-39653 from NMDA receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538777Displacement of [3H]-MK-912 from adrenergic alpha2A receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538927Displacement of [125I]-Leptin from leptin receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538918Displacement of [125I]-(Tyr4) Bombesin from bombesin BB2 receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID1369084Displacement of [3H]-DTG from sigma 2 receptor in rat liver membranes after 120 mins by scintillation counting analysis2018Bioorganic & medicinal chemistry, 01-15, Volume: 26, Issue:2
2-Methyltetrahydro-3-benzazepin-1-ols - The missing link in SAR of GluN2B selective NMDA receptor antagonists.
AID538937Displacement of radiolabeled arachidonic acid from COX1 at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538968Displacement of radiolabeled Poly(Glu:Tyr) from TEK at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538907Displacement of [3H]-DTG from sigma receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538954Displacement of radiolabeled Autocamtide-2 from CAMK2D at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538941Displacement of [3H]-L-Argenine from nNOS at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538924Displacement of [3H]-Quisqulic acid from mGlu5 receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538896Displacement of [3H]alpha,5-Methylene-ATP from purinergic P2X receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538935Displacement of radiolabeled ATP from Na+/K+ ATPase in pig heart at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID1690206Binding affinity to Sigma 1 receptor (unknown origin)
AID538944Displacement of radiolabeled N-alpha-Z-D-Arg-Gly-Arg-pNA from factor 10a at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538758Displacement of [3H]-(+)-MK 801 from NMDA receptor phencyclidine binding site in pig brain cortex after 150 mins by scintillation counting2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538764Half life in rat liver microsomes2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538939Displacement of radiolabeled kynuramine from MAO-B at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538936Displacement of radiolabeled L-[Methyl-14C] from CPT1 at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538801Displacement of [3H]-Idazoxan from imidazoline I2, Central receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538899Displacement of [3H]-GR-65630 from 5-HT3 receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538962Displacement of radiolabeled Histone from PRKCE at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538775Displacement of [3H]-Prazosin from adrenergic Alpha-1B receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538790Displacement of [3H]-Muscimol from agonist site of GABAA receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID1597428Selectivity ratio of Ki for sigma1 receptor in guinea pig brain cortex membranes to ratio of Ki for GluN2B/GluN1a (unknown origin) expressed in mouse L(tk-) cell membranes
AID538912Displacement of radiolabeled Ac-IETD-AMC from CASP8 at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538946Displacement of radiolabeled MOCAc-Ala-Pro-Ala-Lys-Phe-Phe-Arg-Leu-Lys(Dnp)-NH2 from pepsin at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538913Displacement of radiolabeled ATF2 from MAPK8 at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538966Displacement of radiolabeled Poly(Glu:Tyr) from FGFR2 at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538768Analgesic activity in ip dosed mouse assessed as decrease in von Frey filament-induced neuropathic pain2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538931Displacement of [3H]Progesterone from progesterone PR-B receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538794Displacement of [3H]-Kainic acid from kainate receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538885Displacement of [3H]N-Methyl-scopolamine from muscarinic M1 receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538919Displacement of [125I]-TARC from chemokine CCR4 receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538898Displacement of [3H]-8-OH-DPAT from 5-HT1A receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538892Displacement of [3H]Diprenorphine from kappa opioid receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538798Displacement of [3H]-Pyrilamine from histamine H1 receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538793Displacement of [3H]Dexamethasone from glucocorticoid receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538932Displacement of [125I]-Triiodothyronine from thyroid hormone receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538925Displacement of [125I]-Insulin from insulin receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538956Displacement of radiolabeled Axl-tide peptide from DMPK at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538965Displacement of radiolabeled Poly(Glu:Tyr) from FGFR1 at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538958Displacement of radiolabeled IKKtide from IKK-1 at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID1462756Displacement of [3H]-di-o-tolylguanidine from sigma 2 receptor in rat liver membranes after 120 mins by scintillation counting analysis2017Bioorganic & medicinal chemistry, 10-15, Volume: 25, Issue:20
Replacement of benzylic hydroxy group by vinyl or hydroxymethyl moiety at the 3-benzazepine scaffold retaining GluN2B affinity.
AID538782Displacement of [3H]-SCH-23390 from dopamine D1 receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538957Displacement of radiolabeled Myelin basic protein from HIPK2 at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538769Analgesic activity in mouse assessed as decrease in von Frey filament-induced neuropathic pain at 30 mg/kg, ip2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538955Displacement of radiolabeled Autocamtide-2 from CAMK4 at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538776Displacement of [3H]-Prazosin from adrenergic Alpha-1D receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID1272498Binding affinity to sigma-2 receptor (unknown origin) by radioligand displacement assay2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Role of the phenolic OH moiety of GluN2B-selective NMDA antagonists with 3-benzazepine scaffold.
AID538780Displacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID1462755Displacement of [3H](+)-Pentazocine from sigma 1 receptor in guinea pig brain membranes after 120 mins by scintillation counting analysis2017Bioorganic & medicinal chemistry, 10-15, Volume: 25, Issue:20
Replacement of benzylic hydroxy group by vinyl or hydroxymethyl moiety at the 3-benzazepine scaffold retaining GluN2B affinity.
AID1369085Displacement of [3H]-ifenprodil from recombinant human GluN1a/GluN2B expressed in L(tk-) cell membranes after 120 mins by scintillation counting analysis2018Bioorganic & medicinal chemistry, 01-15, Volume: 26, Issue:2
2-Methyltetrahydro-3-benzazepin-1-ols - The missing link in SAR of GluN2B selective NMDA receptor antagonists.
AID538787Displacement of [125I]-Endothelin-1 from ETB receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538933Displacement of [125I]-TGF-beta from TGF-beta receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID1462752Displacement of [3H]ifenprodil from human NR1-1a/NR2B receptor expressed in Mouse L(tk-) cell membranes incubated for 120 mins by scintillation counting method2017Bioorganic & medicinal chemistry, 10-15, Volume: 25, Issue:20
Replacement of benzylic hydroxy group by vinyl or hydroxymethyl moiety at the 3-benzazepine scaffold retaining GluN2B affinity.
AID538967Displacement of radiolabeled Histone H1 from insulin receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538894Displacement of [3H]-PDBu from phorbol ester site of PKC at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538895Displacement of [3H]-PAF from platelet activating factor receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538757Displacement of [3H]-Ifenprodil from polyamine transporter at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538770Analgesic activity in mouse assessed as decrease in von Frey filament-induced neuropathic pain at 10 mg/kg, ip2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538888Displacement of [125I]-Peptide YY from neuropeptide Y1 receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538943Displacement of radiolabeled N-CH3-SO2-D-Phe-Gly-Arg-pNA from factor 7a at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538756Analgesic activity in mouse assessed reduction formalin-induced acute pain at 10 to 100 mg/kg, ip administered 30 mins before formalin challenge measured after 10 to 35 mins2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538774Displacement of [3H]-Prazosin from adrenergic alpha1A receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538763Half life in mouse liver microsomes2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538786Displacement of [125I]-Endothelin-1 from ETA receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538950Displacement of [3H]cAMP from PDE3 at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID1272497Binding affinity to sigma-1 receptor (unknown origin) by radioligand displacement assay2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Role of the phenolic OH moiety of GluN2B-selective NMDA antagonists with 3-benzazepine scaffold.
AID538970Displacement of radiolabeled DiFMUP from ACP1 at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538948Displacement of radiolabeled N-alpha-Z-D-Arg-Gly-Arg-pNA from tissue plasminogen activator at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538904Displacement of [3H]prazosin from adrenergic alpha1 receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538903Displacement of [3H]-Mibolerone from testosterone receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538802Displacement of [125I]-Interleukin-1-alpha from IL-1 at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538923Displacement of [3H]-AMPA from AMPA receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID1462754Displacement of [3H]-(+)-MK-801 from PCP binding site of NMDA receptor in pig brain cortex at 1 uM2017Bioorganic & medicinal chemistry, 10-15, Volume: 25, Issue:20
Replacement of benzylic hydroxy group by vinyl or hydroxymethyl moiety at the 3-benzazepine scaffold retaining GluN2B affinity.
AID538969Displacement of radiolabeled Poly(Glu:Tyr) from ZA70 at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID539062Displacement of [3H]-Ifenprodil from glutamate receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID1597395Displacement of [3H] ifenprodil from GluN2B/GluN1a (unknown origin) expressed in mouse L(tk-) cell membranes incubated for 120 mins by scintillation counting method
AID538947Displacement of radiolabeled Z-Gyl-Pro-Arg-AMC from thrombin at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538922Displacement of [125I]-IL-8 from chemokine CXCR2 receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538784Displacement of [3H Spiperone from dopamine D3 receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538942Displacement of radiolabeled MOCAc-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys(Dnp)-D-Arg-NH2 from cathepsin D at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538908Displacement of radiolabeled arachidonic acid from Cox2 at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538971Displacement of radiolabeled scopoletin from UGT1A1 at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID1272496Displacement of [3H]ifenprodil from recombinant human GluN1a/GluN2B expressed in L(tk-)cells2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Role of the phenolic OH moiety of GluN2B-selective NMDA antagonists with 3-benzazepine scaffold.
AID538799Displacement of [125I]-Aminopotentidine from histamine H2 receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538934Displacement of [125I]-TNF-alpha from TNF receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538945Displacement of radiolabeled glutaryl-Ala-Ala-Phe-4-methoxy-2-naphthylamide from neutral endo-peptidase at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538929Displacement of [3H]-PAF from PAF receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538789Displacement of [3H]-Estradiol from ERalpha receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538886Displacement of [3H]N-Methyl-scopolamine from muscarinic M2 receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538783Displacement of [3H]-Spiperone from dopamine D2 receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538796Displacement of [3H]-MDL-105519 from glycine recognition site of NMDA receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538952Displacement of [3H]-cGMP from PDE6 at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538891Displacement of [3H]Naltrindole from delta opioid receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538766Toxicity in mouse assessed as unusual reactions at 1 to 100 mg/kg, ip after 24 hrs2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538915Displacement of [125I]-C5a Anaphylatoxin from anaphylatoxin C5a at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538772Displacement of [3H]-CGS-21680 from adenosine A2A receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538765Half life in human liver microsomes2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID1369087Displacement of [3H]-(+)-MK-801 from PCP binding site of NMDA receptor in pig brain cortex membranes at 10 uM after 150 mins by solid scintillation counting relative to control2018Bioorganic & medicinal chemistry, 01-15, Volume: 26, Issue:2
2-Methyltetrahydro-3-benzazepin-1-ols - The missing link in SAR of GluN2B selective NMDA receptor antagonists.
AID538963Displacement of radiolabeled ZIPtide from STK17A at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538767Toxicity in mouse assessed as diarrhea at 100 mg/kg, ip after 30 mins2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID1272500Binding affinity to PCP binding site of NMDA receptor (unknown origin) at 10 uM by radioligand displacement assay2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Role of the phenolic OH moiety of GluN2B-selective NMDA antagonists with 3-benzazepine scaffold.
AID538889Displacement of [125I]-Peptide YY from neuropeptide Y2 receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538953Displacement of radiolabeled Suc-LLVY-AMC from proteasome at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538928Displacement of [125I]-NDP-alpha-MSH from melanocortin MC3 receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538916Displacement of [125I]-ANF from atrial natriuretic factor receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538890Displacement of [125I]-epibatidine from nicotinic acetylcholine receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538800Displacement of [3H]R(-)-alpha-Methylhistamine from histamine H3 receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538909Displacement of radiolabeled casein-FITC from CAN1 at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538917Displacement of [125I]-(Tyr4)-Bombesin from bombesin BB1 receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538914Displacement of [3H]D-Aldosterone from aldosterone receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538949Displacement of radiolabeled Z-Gly-Pro-Arg-AMC from trypsin at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538911Displacement of radiolabeled Ac-DEVD-AMC from CASP3 at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538951Displacement of [3H]-cAMP from PDE4 at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538901Displacement of [3H]-Ifenprodil from sigma2 receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID1597396Displacement of [3H]-(+)-MK-801 from NMDA PCP binding site in pig brain cortex membrane at 1 uM incubated for 120 mins by scintillation counting method relative to control
AID538940Displacement of [3H]-L-Argenine + L-Argenine from eNOS at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538964Displacement of radiolabeled CHKtide from TSSK2 at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538803Displacement of [3H]Leukotriene D4 Leukotriene from cysteinyl CysLT1 receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538930Displacement of [3H]-Astemizole from human ERG2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538754Antagonist activity at human recombinant NR1-1a/NR2A receptor expressed in mouse L12-G10 cells assessed as inhibition of (S)-glutamate/glycine-stimulated excitotoxicity at 10 uM treated 30 mins before (S)-glutamate/glycine challenge measured after 4 hrs b2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538961Displacement of radiolabeled MAPKAPK from PKD2 at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID1690205Displacement of [3H]ifenprodil from human GluN2B expressed in mouse L(tk-) cell membranes co-expressing GluN1a incubated for 120 mins by scintillation counting method
AID538792Displacement of [3H]-CGP-54626 from GABAB receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538771Displacement of [3H]-DPCPX from adenosine A1 receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538921Displacement of [125I]-Fractalkine from chemokine CX3CR1 receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538779Displacement of [3H]-CGP-12177 from adrenergic alpha2 receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538785Displacement of [3H]-Spiperone from dopamine D4.2 receptor at 1 to 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
AID538905Displacement of [125I]-CGRP from CGRP1 at 3 uM2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (85.71)24.3611
2020's1 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 13.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index13.00 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index5.08 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (13.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]